Beranda › Infeksi COVID-19 dan Coronavirus
Uji klinis Infeksi COVID-19 dan Coronavirus yang merekrut di AS
24 studi untuk Infeksi COVID-19 dan Coronavirus merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Washington, DC7 studi
- Durham, NC5 studi
- Houston, TX5 studi
- Boston, MA5 studi
- Dallas, TX5 studi
- Atlanta, GA5 studi
- Los Angeles, CA4 studi
- New York City, NY4 studi
- Hialeah, FL4 studi
- San Francisco, CA3 studi
- Chicago, IL3 studi
- Pittsburgh, PA3 studi
- Seattle, WA3 studi
- Cincinnati, OH3 studi
- Mountain View, CA3 studi
- Baltimore, MD3 studi
- Boise, ID3 studi
- Salt Lake City, UT3 studi
Berdasarkan negara bagian
- Alabama3 studi
- California12 studi
- Colorado4 studi
- Distrik Columbia3 studi
- Florida6 studi
- Georgia6 studi
- Idaho3 studi
- Illinois5 studi
- Kentucky3 studi
- Maryland8 studi
- Massachusetts5 studi
- Michigan4 studi
- Minnesota3 studi
- New York6 studi
- North Carolina5 studi
- Ohio7 studi
- Pennsylvania5 studi
- South Carolina3 studi
- Tennessee3 studi
- Texas9 studi
- Utah4 studi
- Virginia4 studi
- Washington3 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence
Menerima pesertaStudi observasional
Usia 7 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT04448145A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07536308Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05624450A Study of COVID-19 Vaccine(s) in Children and Adults
Menerima pesertaFase 3Sukarelawan sehat diterima
Usia 5 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07798648A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07013474Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06631287A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06679140Viral Infections in Healthy and Immunocompromised Hosts
Menerima pesertaStudi observasionalSukarelawan sehat diterima
6 Months – 120 Years · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT01306084Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT04772170Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 0 hingga 20 · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT04278404A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 40 hingga 64 · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT06810934Respiratory Virus Sampling and Repository
Menerima pesertaStudi observasional
Usia 3 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT05266222A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
Menerima pesertaFase 4Sukarelawan sehat diterima
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT07730450Long-term Impact of Infection With Novel Coronavirus (COVID-19)
Menerima pesertaStudi observasional
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT04362150COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 24 Jun 2026 · NCT04391816Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
Menerima pesertaFase 3
Semua usia · Semua jenis kelamin · Diperbarui 23 Jun 2026 · NCT03808922Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Jun 2026 · NCT01904188Impact of the Coronavirus (COVID-19) on Patients With Cancer
Menerima pesertaStudi observasional
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 27 Apr 2026 · NCT04330521ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Apr 2026 · NCT04367857A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
Menerima pesertaFase 4Sukarelawan sehat diterima
6 Months · Semua jenis kelamin · Diperbarui 27 Mar 2026 · NCT06585241Understanding Immunity to the Flu Vaccine in COVID-19 Patients
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 9 hingga 64 · Semua jenis kelamin · Diperbarui 18 Mar 2026 · NCT04579588Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 5 Sep 2025 · NCT05868239Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Mei 2021 · NCT04445285Clazakizumab vs. Placebo - COVID-19 Infection
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2020 · NCT04494724Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.